Pipeline Overview

Developing Drugs for Autism and Fragile X Syndrome

Seaside Therapeutics’ lead drug development programs are focused on creating treatments to correct or improve the course of autism and fragile X syndrome. We are also exploring opportunities to develop novel therapeutics for patients with other neurodevelopmental disorders.